SHERYL MILES: Open Payments
NPI 1245753839 · SANTA MARIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,335 in 60 payments from 16 companies in 2025. Trend: 2023 $208 · 2024 $874 · 2025 $1,335
Food & beverage: $1,325Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $354 |
| Janssen Biotech, Inc. | 8 | $232 |
| UCB, Inc. | 9 | $183 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $86 |
| GENZYME CORPORATION | 2 | $81 |
| Galderma Laboratories, L.P. | 3 | $77 |
| Amgen Inc. | 3 | $65 |
| Organon LLC | 5 | $55 |
| Biofrontera Inc. | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 1 | $35 |
Products named: SKYRIZI, TREMFYA, Bimzelx, Winlevi, DUPIXENT, NEMLUVIO, Otezla, Sotyktu.
Industry payments across CA — which companies pay providers there.
